Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD CME Group Education AD Bank of England Statistics AD Investing.com Markets AD LSEG Data
City & Markets

Theriva Biologics Consensus Price Target Raised 60% to $4.08

Trade Hub UK regulation desk (2026-11-02): The average one-year price target for Theriva Biologics (NYSEAM:TOVX) (DB:SFY0) has been revised to $4.08 / share. This is an increase of 60.00% from the… Primary source: original at Nasdaq (nasdaq.com).

By Nasdaq

Theriva Biologics Consensus Price Target Raised 60% to $4.08

The average one-year price target for Theriva Biologics (NYSEAM:TOVX) (DB:SFY0) has been revised to $4.08 / share. This is an increase of 60.00% from the prior estimate of $2.55 dated October 20, 2026. These figures represent aggregate analyst targets compiled by Fintel and do no

Read at source

Read also
  1. Federal National Mortgage Association Consensus Price Target Decreased by 22.93% to $6.71
  2. Hong Kong and China Gas Company Limited - Depositary Receipt Consensus Price Target Lowered 15.76% to $0.86
  3. Xylem Consensus Price Target Lowered by 12.92% to $126.34
  4. Elmet Group Consensus Price Target Increased by 10% to $28.05
  5. Federal National Mortgage Association - Preferred Stock Price Target Decreased by 42.18% to $9.40

Source: Nasdaq